NAP1L5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.785000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.876400E-01
Normal-vs-Stage2
9.440200E-01
Normal-vs-Stage3
9.183200E-01
Normal-vs-Stage4
6.661400E-01
Stage1-vs-Stage2
5.271900E-02
Stage1-vs-Stage3
3.852000E-01
Stage1-vs-Stage4
5.459400E-01
Stage2-vs-Stage3
8.412200E-01
Stage2-vs-Stage4
5.292800E-01
Stage3-vs-Stage4
7.458400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.519000E-01
Normal-vs-AfricanAmerican
6.881600E-01
Normal-vs-Asian
3.627000E-01
Caucasian-vs-AfricanAmerican
9.206600E-01
Caucasian-vs-Asian
4.620900E-03
AfricanAmerican-vs-Asian
1.397810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.012600E-01
Normal-vs-Female
7.437600E-01
Male-vs-Female
8.596000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.283400E-01
Normal-vs-Age(41-60Yrs)
6.797800E-01
Normal-vs-Age(61-80Yrs)
8.278600E-01
Normal-vs-Age(81-100Yrs)
8.220000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.748000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.072600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.127200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.382800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.631600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.239800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.198200E-01
Normal-vs-Daily Drinker
7.774400E-01
Normal-vs-Weekly Drinker
7.841000E-01
Normal-vs-Occasional Drinker
6.465400E-01
Normal-vs-Social Drinker
3.433800E-01
Non Drinker-vs-Daily Drinker
1.805960E-01
Non Drinker-vs-Weekly Drinker
4.141600E-01
Non Drinker-vs-Occasional Drinker
1.144750E-01
Non Drinker-vs-Social Drinker
2.092400E-01
Daily Drinker-vs-Weekly Drinker
3.384000E-01
Daily Drinker-vs-Occasional Drinker
6.929000E-01
Daily Drinker-vs-Social Drinker
5.715200E-01
Weekly Drinker-vs-Occasional Drinker
2.040000E-01
Weekly Drinker-vs-Social Drinker
2.778400E-01
Occasional Drinker-vs-Social Drinker
7.615600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.028100E-04
Normal-vs-Grade 2
1.433430E-01
Normal-vs-Grade 3
8.458200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.642300E-02
Grade 1-vs-Grade 3
1.202170E-02
Grade 1-vs-Grade 4
6.028100E-04
Grade 2-vs-Grade 3
9.331700E-02
Grade 2-vs-Grade 4
1.433430E-01
Grade 3-vs-Grade 4
8.458200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.912600E-01
Normal-vs-NonDiabetic
7.880600E-01
Diabetic-vs-NonDiabetic
4.390400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.231000E-01
Normal-vs-NoPancreatitis
7.939000E-01
Pancreatitis-vs-NoPancreatitis
7.839400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.116220E-01
Normal-vs-N1
9.936600E-01
N0-vs-N1
6.006000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.075830E-01
Normal-vs-TP53-NonMutant
2.713500E-02
TP53-Mutant-vs-TP53-NonMutant
3.64919999999991E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
